Psyence Biomedical Ltd. (NASDAQ: PBM)
$0.45
+0.0985 ( +27.82% ) 1.5M
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Market Data
Open
$0.45
Previous close
$0.35
Volume
1.5M
Market cap
$5.88M
Day range
$0.34 - $0.50
52 week range
$0.27 - $4.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Jul 05, 2024 |
6-k | Quarterly Reports | 2 | Jun 20, 2024 |
6-k | Quarterly Reports | 2 | Jun 06, 2024 |
6-k | Quarterly Reports | 2 | Mar 15, 2024 |
6-k | Quarterly Reports | 33 | Mar 12, 2024 |
20-f | Annual reports | 18 | Jan 31, 2024 |